Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  34.62 09:39 AM EDT  
    Day High 35.03 04:04 PM EDT
    Range 0.41  
    Volume 1.53 M  
    30-Day Avg Vol 1.95 M
    Difference -21.57%  
    Market Cap 98.64 B  
    Mkt Cap Chg -3.36 B  
    Shares Out 2.83 B  
    % Shrs Traded 0.05%  
    1yr EPS Est 3.52  
    52-Wk Low 27.152 3/9/09
    52-Wk High 49.48 7/9/08
    Range 22.33  
    Prev Close 36.04 7/1/09  
    Today's Open 35.03  
    Change -2.80%
    Dividend (TTM) 1.89778  
    Div Yield (TTM) 5.37%
    Ex-Div Date 04/29/2009
    Div Date 07/09/2009
    Short Interest 5.33 M

    Performance Details

    Revenue (LFY) 44.85 B  
    Earnings (LFY) 8.48 B  
    Earnings (MRQ) 1.62 B  
    Next Earn Est  
    Next Earnings 10/28/2009
    EPS (TTM) 2.92282  
    1yr EPS Growth 8.31%  
    P/E Ratio (TTM) 10.69  
    P/E Ratio (Fwd) 9.90  
    PEG Ratio 6.60  
    Return on Equity 57.35  
    Beta 0.62  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: GSK

    Blogs are not currently available for gsk.

    View all blogs at BloggingStocks.

  • Related Information: GSK

    Company Overview: GSK

    GlaxoSmithKline (GSK) calms your nerves and helps you breathe easier. One of the top five pharmaceutical firms in the world, GSK's top sellers include central nervous system therapies, respiratory drugs, ... View Full Description

    Earnings Analysis: GSK

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter NaN N/A
    Last Quarter 3/31/09 0.64 3/31/09
    2 Quarters Ago 12/31/08 0.60 12/31/08

    Financials: GSK

      Quarterly - 03/31/2009 Annual - 2008
    Total Revenue 9.72 B 44.86 B
    Gross Profit 7.36 B 33.71 B
    Operating Income 2.76 B 14.22 B
    Net Income 1.62 B 8.48 B